Novartis AG (NYSE:NVS)
| 84.26 Delayed Data As of Jul 05 |  -0.02 / -0.02%Today’s Change | 79.09 Today|||52-Week Range 95.17 | -3.67% Year-to-Date |
Latest NVS News | Press Releases
Today’s Trading
| Previous close | 84.28 |
| Today’s open | 83.68 |
| Day’s range | 83.34 - 84.29 |
| Volume | 1 |
| Average volume (3 months) | 2,450,284 |
| Market cap | $186.7B |
Data as of 3:59pm ET, 07/05/2022
Growth & Valuation
| Earnings growth (last year) | +202.15% |
| Earnings growth (this year) | -92.73% |
| Earnings growth (next 5 years) | +5.24% |
| Revenue growth (last year) | +6.10% |
| P/E ratio | 7.9 |
| Price/Sales | 3.83 |
| Price/Book | 2.79 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NVONovo Nordisk | -0.06 | -0.05% |
| AZNAstraZeneca | -0.44 | -0.67% |
| BMYBristol-Myers Squibb | -0.88 | -1.15% |
| MRKMerck | +0.01 | +0.01% |
Data as of 5:01pm ET, 07/05/2022
Financials
| Next reporting date | July 19, 2022 |
| EPS forecast (this quarter) | $1.52 |
| Annual revenue (last year) | $51.6B |
| Annual profit (last year) | $24.0B |
| Net profit margin | 46.53% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Basel, Basel-stadt (basle Town) |
Forecasts
